Fdx Cgn secondaries
#11
Maybe….or it could simply mean they are replacing CGN Captains who Bid out on the Practice Bid by awarding CGN secondaries.
#12
First, the CBA in section 24 provided the provision that an Excess can not be "created" at an FDA, however if a pilot in a seat declared in excess bid to an FDA (and had the seniority and ability to actually bid out of his current excessed seat) that the pilot would be pay protected for being denied said seat. Well this CBA provision was the subject of a Grievance because of "when" does the pilot denied the FDA seat begin receiving the pay? More on that later. Back to the CBA and section 24, the pilot(s) who were in a seat declared in excess and wanted to either bid to relieve or be forced "excessed" into the FDA were either awarded a different seat or in some cases actually stayed in their current seats and now became eligible for FDA passover pay. So the second part of this equation is the actual posting awards, provides you with a list of who actually "owns" a seat award. Any pilot that was denied an FDA award is NOT on an FDA seat in the bid awards and will not show up in the training letter.
Back to the Grievance, so the Union and Company ended up settling the issue with the publishing of the "FEPP" agreement. That can be found in the Company CBA online or the ALPA web site. This agreement dictates the whole administration of the passover pay.
Now when subsequent bids are run any seats opened up in HKG or CGN via primary awards or secondary those seats are available to ANY pilot who bids them as the pilots on "FEPP" only have a pay protection and no "claim" to the seat since they where not awarded one per the CBA when they first became eligible.
So to answer your question , it is written down via:
Section 24 (FDA excess provision)
Section 24 (actual bid awards and training letters) and
FEPP Settlement procedures
If you have any question call ALPA Contract Enforcement as they are well versed on the subject.
Thread
Thread Starter
Forum
Replies
Last Post